Pediatric Diabetic Ketoacidosis - ICU Management of Fluids and Electrolytes

Key Points

• Pediatric DKA treatment continues until ketosis and acidosis resolve, not simply until glucose normalizes.
• Begin isotonic fluids first, then start low-dose IV insulin without an insulin bolus.
• Total-body potassium is depleted even when the first serum potassium is normal or high.
• Add dextrose as glucose falls so insulin can continue clearing ketones.
• Routine bicarbonate therapy is not recommended in pediatric DKA.
• New headache, declining mental status, bradycardia, incontinence, cranial nerve findings, or recurrent vomiting can signal cerebral injury.
• Treat suspected cerebral injury immediately with hyperosmolar therapy; do not wait for neuroimaging.

Algorithm

1. Confirm hyperglycemia, acidosis, and ketonemia, and assess perfusion and neurologic status.
2. Obtain glucose, blood gas, electrolytes, renal function, and beta-hydroxybutyrate; identify infection or another precipitant when indicated.
3. Begin isotonic fluid according to shock status and the pediatric DKA protocol.
4. Start regular insulin infusion after initial fluids when potassium is safe.
5. Replace potassium according to serum level, ECG risk, renal function, and urine output.
6. Add dextrose to IV fluid before glucose becomes low so insulin can continue until ketones clear.
7. Monitor neurologic status and biochemical response frequently; treat cerebral injury immediately if suspected.
8. Transition to subcutaneous insulin only after DKA resolution with appropriate overlap and a prevention plan.

Clinical Synopsis & Reasoning

Pediatric DKA is defined by hyperglycemia, metabolic acidosis, and ketonemia or significant ketonuria in a child with diabetes or new-onset diabetes. Common precipitants are delayed diagnosis of type 1 diabetes, missed insulin, insulin-pump interruption, infection, and psychosocial barriers to treatment. Polyuria, polydipsia, weight loss, abdominal pain, vomiting, dehydration, Kussmaul respirations, and fruity breath are typical. Children can present with near-normal blood pressure despite substantial fluid deficit, so perfusion, mental status, capillary refill, pulse quality, and urine output should be assessed together.

The initial laboratory profile should include bedside glucose, venous blood gas, electrolytes, urea and creatinine, and serum beta-hydroxybutyrate when available. The measured serum sodium is often low because hyperglycemia draws water into the extracellular space; corrected sodium and its trajectory help assess water balance. Total-body potassium is depleted even when the initial serum potassium is normal or elevated, because acidosis and insulin deficiency shift potassium out of cells. Phosphate is also depleted, but routine phosphate replacement is unnecessary unless there is severe hypophosphatemia or a specific clinical indication.

Cerebral injury is the complication clinicians fear most. Warning findings include new or worsening headache, irritability, declining consciousness, recurrent vomiting after treatment begins, incontinence in a previously continent child, cranial nerve abnormalities, bradycardia, rising blood pressure, or oxygen desaturation. Cerebral injury can occur before treatment, so it should not be simplistically attributed to fluid administration. Differential diagnoses for altered consciousness include hypoglycemia, severe acidosis, sepsis, intoxication, and electrolyte disturbance. Hyperglycemic hyperosmolar state and mixed DKA/HHS require modified fluid and electrolyte strategies because water deficits and osmolality are greater.

Treatment Strategy & Disposition

Start isotonic IV fluid to restore circulation and begin replacing the estimated deficit. Children in shock require prompt resuscitation boluses with reassessment; those who are not in shock generally receive a more measured initial infusion followed by deficit replacement over roughly 24 to 48 hours according to the protocol used. Current pediatric guidance does not support deliberately restricting appropriate fluids out of fear of cerebral edema. The key is protocolized replacement with careful sodium, osmolality, hemodynamic, and neurologic monitoring.

Begin regular insulin infusion after initial fluid therapy, typically 0.05 to 0.1 units/kg/hour, without an IV insulin bolus. Insulin should continue until acidosis and ketonemia resolve, not merely until the glucose reaches a target. Add dextrose to IV fluid as glucose falls so insulin can continue suppressing ketogenesis. Potassium replacement is usually required once the serum level and renal function are known. If potassium is dangerously low, begin potassium first and delay insulin until the level is safer because insulin can precipitate life-threatening arrhythmia and weakness. If initial potassium is high, monitor closely and begin replacement when it falls and urine output is established.

Check bedside glucose frequently and electrolytes, gas, and beta-hydroxybutyrate at regular protocol-defined intervals. Bicarbonate is not routine and can worsen potassium shifts and possibly cerebral risk; reserve it for exceptional situations such as life-threatening hyperkalemia or profound acidosis compromising circulation after expert consultation. If cerebral injury is suspected, treat immediately rather than waiting for CT. Hypertonic saline or mannitol is used according to pediatric DKA protocol, reduce unnecessary fluid burden if appropriate, elevate the head, and obtain critical care and neurologic support. Transition to subcutaneous insulin only after ketoacidosis has resolved and the child can tolerate intake, with overlap between the first subcutaneous dose and discontinuation of the IV infusion to avoid rebound ketosis.

Epidemiology / Risk Factors

• DKA remains a common cause of diabetes-related hospitalization in children and adolescents.
• A substantial proportion of children with new type 1 diabetes first present in DKA.
• Adolescents with psychosocial stress, disordered eating, limited access to insulin, or recurrent omission are at increased risk of recurrent DKA.
• Cerebral injury is uncommon but accounts for a large share of DKA-related pediatric mortality.

Investigations

Cerebral Injury Clues

Pharmacology

Prognosis / Complications

• Most children recover fully with protocolized fluid, insulin, and electrolyte treatment.
• Neurologic outcome depends on early recognition and treatment of cerebral injury.
• Recurrent DKA strongly predicts future morbidity and signals a need for intensive diabetes, psychosocial, and access support.
• Acute kidney injury and electrolyte disturbances usually resolve with treatment but can complicate severe dehydration or shock.

Patient Education / Counseling

• Before discharge, review exactly why DKA occurred and address the precipitating barrier rather than repeating generic diabetes teaching.
• Families should know never to stop basal insulin during illness without clinician guidance.
• Teach blood or urine ketone testing, pump troubleshooting, hydration, carbohydrate intake, and when to call the diabetes team.
• Provide explicit emergency warning signs including persistent vomiting, rapid breathing, large ketones, altered consciousness, and inability to keep fluids down.
• For recurrent DKA, involve social work, behavioral health, school support, or insurance assistance when those factors contribute.

Notes

The safest pediatric DKA management is protocolized but not mechanical. Fluids, insulin, potassium, glucose, sodium, and neurologic status interact continuously. A child whose glucose is falling appropriately can still be getting worse neurologically, and a child whose glucose has normalized can remain substantially ketoacidotic. The bedside team should therefore follow ketone clearance and acid-base recovery in parallel with glucose.

Modern evidence has also shifted the discussion about fluids. Appropriate isotonic resuscitation and deficit replacement should not be withheld because of an oversimplified belief that fluid itself causes cerebral edema. Cerebral injury is multifactorial and can precede treatment. The practical safety strategy is adequate circulation, protocol-based replacement, repeated neurologic examination, and immediate hyperosmolar treatment when concerning signs emerge.

References

1. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state — Link
2. ISPAD Clinical Practice Consensus Guidelines — Link